Alaunos Therapeutics, Inc. (TCRT) Q4 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Alano Therapeutics 4th Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising you your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Danielle Dungeon with Stern IR. Please go ahead. Danielle Dungeon Good morning and welcome to the ALONOS Therapeutics fourth quarter and full year 2022 financial results conference call and audio webcast. Earlier this morning, ALONOS issued a press release announcing financial results for the three months and full year ended December 31, 2022. We encourage everyone to read today's press release, as well as the Alanos annual report on Form 10-K for the year ended December 31st, 2022, which was filed with the SEC this morning. The company's press release and annual report will also be available on the Alanos website at alanos.com. In addition, this conference call is being webcast through the investor relations section of the company's website and will be archived there for future reference. Please note that certain information discussed on today's call is covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Participants are cautioned that this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, March 7, 2023. Actual results could differ materially from those state...